首页/数据集/Dataset from A Follow-up of a Phase 3 Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel in the Treatment of Complex Perianal Fistula in Subjects With Crohn's Disease Who Have Participated in ADMIRE II Study

Dataset from A Follow-up of a Phase 3 Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel in the Treatment of Complex Perianal Fistula in Subjects With Crohn's Disease Who Have Participated in ADMIRE II Study

NIAID Data Ecosystem2026-05-02 收录

克罗恩病肛瘘治疗

长期药物疗效评估

数据链接：

https://doi.org/10.25934/PR00011095 数据链接链接失效反馈

官方服务：

资源简介：

The main aim is to follow-up on long term side effect and symptom improvement of Darvadstrocel in the treatment of complex perianal fistula in adults. Participants will not receive any drug in this study.

应用场景：

创建时间：

2025-06-25

克罗恩病肛瘘治疗

临床试验药物疗效评估

The purpose of this study is to evaluate the percentage of participants with perianal fistula healing at Week 30 in 2 different dose regimens of vedolizumab intravenous (IV) 300 milligram (mg) in pa

NIAID Data Ecosystem20

Dataset from A 28-Week, Multi-Center, Randomized, Double Blind, Parallel-Group, Active-Controlled Safety Extension Study to Evaluate the Safety and Efficacy of PT003, PT001, and PT005 in Subjects With Moderate to Very Severe COPD, With Spiriva® Handihaler® as an Active Control

COPD药物安全性

长期药物疗效评估

This is a multi-center, randomized, double-blind, parallel group, chronic dosing, active-controlled, 28-week safety extension study of the two pivotal 24-week safety and efficacy studies (Studies PT

NIAID Data Ecosystem00

A preclinical platform for assessing long-term drug efficacy exploiting mechanically tunable scaffolds colonized by a three-dimensional tumor microenvironment

肿瘤微环境

长期药物疗效评估

Background: Long-term drug evaluation heavily relies upon rodent models. Drug discovery methods to reduce animal models in oncology may include three-dimensional (3D) cellular systems that take into a

NIAID Data Ecosystem00

Clinical outcomes of long-term infliximab treatment for 15 years in patients with Crohn’s disease: a retrospective study

克罗恩病生物制剂治疗

长期药物疗效评估

While clinical trials have demonstrated that approximately 50% of patients with Crohn’s disease (CD) maintain clinical remission at 1 year with infliximab (IFX), the outcomes of long-term IFX treatmen

Figshare2026-02-20 更新10

A Follow-up of a Phase 3 Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel in the Treatment of Complex Perianal Fistula in Subjects With Crohn's Disease Who Have Participated in ADMIRE II Study

克罗恩病肛瘘治疗

药物长期疗效评估

DataCite Commons2025-06-25 更新00